Dcm Advisors, LLC Abb Vie Inc. Transaction History

Dcm Advisors, LLC

$197 Million
Q3 2024

A detailed history of Dcm Advisors, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Dcm Advisors, LLC holds 27,795 shares of ABBV stock, worth $4.96 Million. This represents 2.78% of its overall portfolio holdings.

Number of Shares

27,795

Previous 27,795 -0.0%

Holding current value

$4.96 Million

Previous $4.77 Million 15.12%

% of portfolio

2.78%

Previous 2.53%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$154.79 - $180.76 $694,387 - $810,889	-4,486 Reduced 13.9%	27,795 $4.77 Million
Q1 2024 May 15, 2024	SELL	$159.82 - $182.1 $1.25 Million - $1.42 Million	-7,804 Reduced 19.47%	32,281 $5.88 Million
Q4 2023 Feb 14, 2024	BUY	$137.6 - $154.97 $749,507 - $844,121	5,447 Added 15.73%	40,085 $6.21 Million
Q3 2023 Nov 13, 2023	SELL	$133.59 - $154.65 $126,776 - $146,762	-949 Reduced 2.67%	34,638 $5.16 Million
Q2 2023 Sep 12, 2023	BUY	$132.51 - $164.9 $64,664 - $80,471	488 Added 1.39%	35,587 $4.79 Million
Q1 2023 Sep 12, 2023	SELL	$144.61 - $166.54 $38,032 - $43,800	-263 Reduced 0.74%	35,099 $5.59 Million
Q4 2022 Sep 08, 2023	BUY	$138.31 - $165.87 $1.9 Million - $2.28 Million	13,725 Added 63.43%	35,362 $5.72 Million
Q3 2022 Sep 08, 2023	SELL	$134.21 - $153.93 $50,597 - $58,031	-377 Reduced 1.71%	21,637 $2.9 Million
Q2 2022 Aug 15, 2022	BUY	$137.62 - $174.96 $143,124 - $181,958	1,040 Added 4.96%	22,014 $3.37 Million
Q1 2022 May 09, 2022	SELL	$131.98 - $163.75 $29,035 - $36,025	-220 Reduced 1.04%	20,974 $3.4 Million
Q4 2021 Feb 11, 2022	BUY	$107.43 - $135.93 $1.06 Million - $1.35 Million	9,910 Added 87.82%	21,194 $2.87 Million
Q3 2021 Nov 15, 2021	BUY	$106.4 - $120.78 $1.2 Million - $1.36 Million	11,284 New	11,284 $1.22 Million

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $315B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Dcm Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Dcm Advisors, LLC with notifications on news.

Account